Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Julphar
Chinese Patent Office
Chubb
Cipla

Generated: July 21, 2019

DrugPatentWatch Database Preview

Patent: 8,529,943

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,529,943
Title:Angiopoietin derived peptides
Abstract: Provided are angiopoietin-derived peptides or homologs or derivatives thereof, pharmaceutical composition including them, a use thereof for therapy and for the manufacture of a medicament, a method of treating a wide range of conditions, disorders and diseases therewith, nucleotide sequences encoding them, antibodies directed to epitopes thereof and fusion proteins including them.
Inventor(s): Kliger; Yossef (Rishon Le Zion, IL), Borukhov; Itamar (Ramat Hasharon, IL), Levy; Ofer (D.N Shimshon, IL), Tiran; Zohar (Oranit, IL), Wool; Assaf (Kiryat Ono, IL), Schreiber; Ehud (Ramat Gan, IL), Amir; Anat (D.N. Negev, IL), Levine; Zurit (Herzliya, IL), Toporik; Amir (Pardess Channa, IL)
Assignee: Compugen Ltd. (Tel-Aviv, IL)
Application Number:13/054,914
Patent Claims:see list of patent claims

Details for Patent 8,529,943

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26 ➤ Sign Up Compugen Ltd. (Tel-Aviv, IL) ➤ Sign Up RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26 ➤ Sign Up Compugen Ltd. (Tel-Aviv, IL) ➤ Sign Up RX search
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18 ➤ Sign Up Compugen Ltd. (Tel-Aviv, IL) ➤ Sign Up RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Cipla
Covington
Argus Health
US Army
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.